Medtronic PLC (MDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtronic PLC (MDT) has a cash flow conversion efficiency ratio of 0.056x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.74 Billion) by net assets ($49.20 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Medtronic PLC's balance sheet to measure how much of total assets are equity-financed.
Medtronic PLC - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Medtronic PLC's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
INTESA SANPAOLO ADR/6
F:IESJ
|
N/A |
|
AIR LIQUIDE ADR 1/5/EO 11
F:AILA
|
N/A |
|
Medtronic plc
SA:MDTC34
|
0.051x |
|
Mizuho Financial Group Inc.
NYSE:MFG
|
-0.200x |
|
Trane Technologies plc
NYSE:TT
|
0.136x |
|
BNP Paribas SA
PA:BNP
|
0.004x |
|
Pinduoduo Inc
F:9PDA
|
0.039x |
|
Sanofi
MX:SNYN
|
0.023x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2025)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see Medtronic PLC (MDT) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $48.26 Billion | $7.04 Billion | 0.146x | +8.44% |
| 2024-04-30 | $50.42 Billion | $6.79 Billion | 0.135x | +15.16% |
| 2023-04-30 | $51.66 Billion | $6.04 Billion | 0.117x | -16.11% |
| 2022-04-30 | $52.72 Billion | $7.35 Billion | 0.139x | +15.22% |
| 2021-04-30 | $51.60 Billion | $6.24 Billion | 0.121x | -14.96% |
| 2020-04-30 | $50.87 Billion | $7.23 Billion | 0.142x | +1.90% |
| 2019-04-30 | $50.21 Billion | $7.01 Billion | 0.140x | +51.41% |
| 2018-04-30 | $50.82 Billion | $4.68 Billion | 0.092x | -32.46% |
| 2017-04-30 | $50.42 Billion | $6.88 Billion | 0.136x | +35.54% |
| 2016-04-30 | $51.83 Billion | $5.22 Billion | 0.101x | +9.33% |
| 2015-04-30 | $53.23 Billion | $4.90 Billion | 0.092x | -63.89% |
| 2014-04-30 | $19.44 Billion | $4.96 Billion | 0.255x | -2.48% |
| 2013-04-30 | $18.67 Billion | $4.88 Billion | 0.262x | +0.12% |
| 2012-04-30 | $17.11 Billion | $4.47 Billion | 0.261x | +11.49% |
| 2011-04-30 | $15.97 Billion | $3.74 Billion | 0.234x | -17.03% |
| 2010-04-30 | $14.63 Billion | $4.13 Billion | 0.282x | -6.42% |
| 2009-04-30 | $12.85 Billion | $3.88 Billion | 0.302x | -0.22% |
| 2008-04-30 | $11.54 Billion | $3.49 Billion | 0.302x | +11.44% |
| 2007-04-30 | $10.98 Billion | $2.98 Billion | 0.271x | +15.35% |
| 2006-04-30 | $9.38 Billion | $2.21 Billion | 0.235x | -12.80% |
| 2005-04-30 | $10.45 Billion | $2.82 Billion | 0.270x | -13.94% |
| 2004-04-30 | $9.08 Billion | $2.85 Billion | 0.314x | +19.28% |
| 2003-04-30 | $7.91 Billion | $2.08 Billion | 0.263x | +6.30% |
| 2002-04-30 | $6.43 Billion | $1.59 Billion | 0.247x | -25.62% |
| 2001-04-30 | $5.51 Billion | $1.83 Billion | 0.332x | +43.29% |
| 2000-04-30 | $4.49 Billion | $1.04 Billion | 0.232x | +86.22% |
| 1999-04-30 | $3.65 Billion | $455.30 Million | 0.125x | -63.26% |
| 1998-04-30 | $2.04 Billion | $693.10 Million | 0.339x | +27.71% |
| 1997-04-30 | $1.75 Billion | $463.60 Million | 0.265x | -5.09% |
| 1996-04-30 | $1.79 Billion | $500.50 Million | 0.280x | -3.56% |
| 1995-04-30 | $1.33 Billion | $387.20 Million | 0.290x | -14.39% |
| 1994-04-30 | $1.05 Billion | $356.90 Million | 0.339x | -2.20% |
| 1993-04-30 | $841.50 Million | $291.50 Million | 0.346x | +82.24% |
| 1992-04-30 | $796.50 Million | $151.40 Million | 0.190x | +2.58% |
| 1991-04-30 | $683.20 Million | $126.60 Million | 0.185x | -6.13% |
| 1990-04-30 | $541.00 Million | $106.80 Million | 0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more